Coronavirus vaccine developer CureVac raises $213 million in IPO - source

CureVac BV raised $213 million in its initial public offering on Thursday, a person familiar with the matter said, setting the stage for the first stock market debut of a company developing a promising vaccine to combat the novel coronavirus.

from Top Business News- News18.com https://ift.tt/3kISjgb
via IFTTT